Apr 2021 - The next joint webinar from EUREOS and TIGERS will take place on June 16th. Here's the speakers, registration and agenda for the virtual event Read more
Nov 2020 - Growing evidence that Eosinophilic Gastritis and Eosinophilic Gastroenteritis are under-diagnosed. 58% of moderate-severely symptomatic patients without diagnoses who entered the ENIGMA study met histologic criteria for EG/EGE Read more
Oct 2020 - Dupixent® (dupilumab) Late-breaking Pivotal Data Showing Significant Improvement in Eosinophilic Esophagitis Signs and Symptom Read more
Mar 2020 - Video from CEGIR with an update on Covid-19 and Eosinophilic Diseases Read more
A UK and Ireland survey on the management of paediatric eosinophilic oesophagitis for gastroenterologists. Read more
May 2021 - The annual Digestive Disease Week is coming up on the 21st - 23rd of May, with all three days featuring talks on EGIDs. There is also a Medscape CME live session on lower EGIDs that is available to DDW ticket holders. Read more
Mar 2021 - Phase 3 trial shows Dupilimab to improve health-related quality of life and reduces symptom burden in patients with EoE. Read more
Mar 2021 - Study finds Budesonide Oral Suspension improves multiple outcomes for children 11-17 with EoE. The drug taken twice-daily improved histologic, endoscopic, and combined histologic and symptomatic outcomes in children with EoE. Read more
Jan 2021 - We need you to answer our survey to help us develop an action plan for when food gets stuck in the oesophagus. Help us get it right! Read more
Following November's success, EUREOS and TIGERS hosted another interactive webinar on March 3rd. Talks include dietary treatments in EoE and monitoring treatment response. Catch up on the recording Read more
Jan 2021 - The International Eosinophil Society (IES) is holding a virtual seminar on 'Eosinophils and COVID'. Talks will include the involvement of eosinophils in viral infections, Covid-19 and eosinophilic diseases, and vaccine hypersensitivity. Read more
Jan 2021 - The US FDA has granted priority review for Takeda's new budesonide oral suspension for treatment of eosinophilic oesophagitis (EoE). If successful, TAK-721 will be the first EoE treatment to be approved in the US. Read more
Dec 2020 - AstraZeneca has begun its Phase 3 trial evaluating Fasenra in EoE and other eosinophilic diseases. It has also announced a further Phase 3 trial evaluating the drug for EG and EGE. Read more
Nov 2020 - Allakos have published the results of the ENIGMA Phase 2 study of Lirentelimab for EG and EGE patients, showing meaningful and statistically significant benefits. The study appears in the October 2020 edition of the NEJM Read more
Nov 2020 - On November 30th, EUREOS and TIGERS are holding the first joint meeting on Challenges in EoE, a global webinar for HCPs, researchers and industry representatives. Read more
Nov 2020 - We were proud to speak at the EUREOS Eosinophilic Gastrointestinal Diseases Symposium in October, with our Chair Amanda Cordell presenting on the Patient Perspective of living with EoE. Read more
Oct 2020 - RAREfest20 is an interactive event on the 28th November celebrating the stories, science and organisations improving the lives of people with rare diseases. Read more
Oct 2020 - This year's Student Voice Prize information, questions. details on how to apply and the prizes. Read more
May 2020 - USA National Institute of Health Support Research In Covid-19 and Rare Diseases Including Eosinophilic Diseases- Read the full article here Read more
Feb 2020 - Research into blood and tissue markers for EG Eosinophilic Disease study published by CEGIR. Read more
Jorveza - Budesonide in an Orodispersible tablet the only EOE drug approved by European Medical Agency - read the full article Read more
Oct 2019 - Allakos Announces Multiple Presentations from Its Eosinophilic Gastrointestinal Diseases Program at the American College of Gastroenterology (ACG) 2019 Annual Scientific Meeting. Read more